CA1228549A - Utilisation des 1,4-dihydropyridines contre l'arteriosclerose et preparations a cet effet - Google Patents

Utilisation des 1,4-dihydropyridines contre l'arteriosclerose et preparations a cet effet

Info

Publication number
CA1228549A
CA1228549A CA000430227A CA430227A CA1228549A CA 1228549 A CA1228549 A CA 1228549A CA 000430227 A CA000430227 A CA 000430227A CA 430227 A CA430227 A CA 430227A CA 1228549 A CA1228549 A CA 1228549A
Authority
CA
Canada
Prior art keywords
composition according
dihydropyridine
dosage unit
nitro
tablets
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000430227A
Other languages
English (en)
Inventor
Friedel Seuter
Friedrich Bossert
Horst Meyer
Egbert Wehinger
Horst Boshagen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA1228549A publication Critical patent/CA1228549A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA000430227A 1982-06-15 1983-06-13 Utilisation des 1,4-dihydropyridines contre l'arteriosclerose et preparations a cet effet Expired CA1228549A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823222367 DE3222367A1 (de) 1982-06-15 1982-06-15 Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
DEP3222367.6 1982-06-15

Publications (1)

Publication Number Publication Date
CA1228549A true CA1228549A (fr) 1987-10-27

Family

ID=6166052

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000430227A Expired CA1228549A (fr) 1982-06-15 1983-06-13 Utilisation des 1,4-dihydropyridines contre l'arteriosclerose et preparations a cet effet

Country Status (9)

Country Link
JP (1) JPS595114A (fr)
BE (1) BE897035A (fr)
CA (1) CA1228549A (fr)
DE (1) DE3222367A1 (fr)
ES (1) ES523244A0 (fr)
FR (1) FR2528425B1 (fr)
IL (1) IL68970A0 (fr)
IT (1) IT1175920B (fr)
ZA (1) ZA834344B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
GB2180532B (en) * 1985-09-17 1989-08-23 Inst Organicheskogo Sinteza Ak Alkoxy-and phenoxy-alkyl-esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid
DE4222770A1 (de) * 1992-07-10 1994-01-13 Bayer Ag Lichtaktivierbare 1-(2-Nitrobenzyl)-substituierte 1,4-Dihydropyridine
DE4328884A1 (de) * 1993-08-27 1995-03-02 Bayer Ag Verwendung von N-alkylierten 1,4-Dihydropyridincarbonsäureestern als Arzneimittel
AU2002361992A1 (en) * 2001-12-20 2003-07-09 Bayer Aktiengesellschaft 1,4-dihydro-1,4-diphenylpyridine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117573C3 (de) * 1971-04-10 1978-07-27 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel
DE2335466A1 (de) * 1973-07-12 1975-01-30 Bayer Ag Alkoxyalkyl-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2549568C3 (de) * 1975-11-05 1981-10-29 Bayer Ag, 5090 Leverkusen 2,6-Dimethyl-3-methoxycarbonyl-4- (2'-nitrophenyl)-1,4-dihydropyridin-5- carbonsäureisobutylester, mehrere Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DE3222367A1 (de) 1983-12-15
IT8321465A0 (it) 1983-06-03
FR2528425A1 (fr) 1983-12-16
JPS595114A (ja) 1984-01-12
IT1175920B (it) 1987-08-12
BE897035A (fr) 1983-12-13
JPH0553774B2 (fr) 1993-08-10
DE3222367C2 (fr) 1992-02-13
ZA834344B (en) 1984-03-28
ES8403456A1 (es) 1984-03-16
ES523244A0 (es) 1984-03-16
FR2528425B1 (fr) 1987-02-06
IL68970A0 (en) 1983-10-31

Similar Documents

Publication Publication Date Title
DK160549B (da) Analogifremgangsmaade til fremstilling af antipoder i s-form af chirale 1,4-dihydropyridincarboxylsyreestere
CZ127396A3 (en) Short time acting dihydropyridines
CA1228549A (fr) Utilisation des 1,4-dihydropyridines contre l'arteriosclerose et preparations a cet effet
OA12648A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
JPS6360755B2 (fr)
US4258042A (en) Antihypertensive pyridines and compositions
PL84190B1 (en) 3-aroyl-alkenyleneimines[us3835149a]
US4501748A (en) 1,4-Dihydropyridine derivatives
IE43984B1 (en) A 1,4-dihydropyridine-3 5-dicarboxylic acid di-ester derivative, several processes for its preparation,and its use as a coronary therapeutic agent
US4520131A (en) Antihypertensive N-substituted 1,4-dihydropyridines
EP0106276B1 (fr) Dérivés de 1,4-dihydropyridine
US5530001A (en) Pharmaceutical use of dihydropyridine derivative
US5051433A (en) Pharmaceutically active basic nitro-phenyl-dihydropyridine amides
US4801591A (en) 2-alkenylene-thieno-1,2-thiazole derivatives with lipid-lowering activity
JPS58201764A (ja) ジヒドロピリジン誘導体
US4742068A (en) Dihydropyridine compounds having 1,4,4-trisubstitution useful as antihypertensive agents
US4086343A (en) Acylated hydrazinopyridazine antihypertensives
EP0216542B1 (fr) Dérivés de la dihydropyridine
US4500532A (en) 1-(Substituted aminoalkyl)-1,4-dihydropyridines
JPH0155268B2 (fr)
US4675329A (en) Isopropyl 2-(3-trifluoromethylphenoxy)-ethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate as vaso-dilators
CA2028394A1 (fr) Derives de dihydropyridine et compositions pharmaceutiques
HU197304B (en) Process for producing fluor-containing 1,4-dihydro-pyridines and pharmaceutical compositions containing them
NO163327B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.
EP0463407B1 (fr) Utilisation des dérivés de la dihydropyridine dans des compositions pharmaceutiques cardiotoniques

Legal Events

Date Code Title Description
MKEX Expiry